NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-232-2009-0-AU-07 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System AU DIV 2014256364 Abandoned
NCI E-008-2014-2-PCT-01 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same PCT PCT COMB PCT/US2014/063096 Expired
NICHD E-001-2007-0-US-09 Conjugates of Plasmodium Falciparum Surface Proteins As Malaria Vaccines US DIV 14/527,676 Abandoned
NCI E-141-2008-0-HK-27 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof HK National Stage 14110833.4 Pending
NCI E-141-2008-0-HK-26 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof HK National Stage 14110832.5 Pending
NIBIB E-247-2014-0-US-01 Systems and Methods for Distinguishing Stimulated Emission As A Means Of Increasing The Signal Of Fluorescence Microscopy US 62/072,218 Abandoned
NCI E-188-2010-1-US-02 Human Monoclonal Antibody Against Human Folate Receptor Beta US CON 14/524,304 9914773 Issued PDF
NCI E-230-2011-1-US-05 Vascular Endothelial Growth Factor Antagonists And Methods For Their Use US National Stage 14/397,435 9550818 Issued PDF
NHLBI E-018-2014-0-PCT-02 Atrial Appendage Ligation PCT PCT PCT/US2014/062364 Expired
NHLBI E-018-2014-0-EP-03 Atrial Appendage Ligation EP National Stage 14855406.6 Abandoned
NHLBI E-051-2019-0-KR-03 METHODS AND SYSTEMS FOR AUTOMATICALLY DETERMINING MAGNETIC FIELD INVERSION TIME OF A TISSUE SPECIES KR ORD 20140124733 Pending
NCI E-294-2011-0-US-05 Use Of CpG Oligonucleotides Co-formulated With an Antibiotic To Accelerate Wound Healing US National Stage 14/397,156 10076535 Issued PDF
NEI E-036-2012-0-JP-06 Methods of Producing and Using Regulatory B-Cells JP National Stage 2015-509008 Issued
NIDCR E-109-2000-0-US-06 Selective Ablation of Pain-Sensing Neurons By Administration of A Vanilloid Receptor Agonist US DIV 14/523,752 9827223 Expired PDF
NIAID E-449-2013-1-EP-04 SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING EP National Stage 14800182.9 Abandoned
NIAID E-449-2013-1-CA-03 SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING CA National Stage 2927952 Abandoned
NIAID E-449-2013-1-AU-02 SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING AU National Stage 2014340035 Abandoned
NEI E-036-2012-0-US-07 Methods of Producing and Using Regulatory B-Cells US National Stage 14/396,475 9629897 Issued PDF
NCI E-019-2014-2-PCT-01 COMPOUNDS THAT BIND TO HUMAN IMMUNODEFICIENCY VIRUS REV RESPONSE ELEMENT PCT PCT COMB PCT/US2014/061975 Expired
NIAID E-449-2013-1-PCT-01 SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING PCT PCT COMB PCT/US2014/061917 Expired
NCI E-520-2013-0-CA-04 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use CA National Stage 2928140 Issued
CC E-198-2011-0-US-08 Imaging Thermometry US National Stage 14/396,064 10743773 Issued PDF
NCI E-520-2013-0-AU-03 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use AU National Stage 2014340201 Issued
NCI E-520-2013-0-CH-10 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use CH EP 14802730.3 Issued
NCI E-520-2013-0-GB-14 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use GB EP 14802730.3 Issued
NCI E-520-2013-0-EP-05 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use EP National Stage 14802730.3 Issued
NCI E-520-2013-0-IE-15 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use IE EP 14802730.3 Issued
NCI E-520-2013-0-IT-16 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use IT EP 14802730.3 Issued
NCI E-520-2013-0-FR-13 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use FR EP 14802730.3 Issued
NCI E-520-2013-0-DE-11 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use DE EP 14802730.3 Issued
NCI E-520-2013-0-ES-12 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use ES EP 14802730.3 Issued
NCI E-520-2013-0-PCT-02 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use PCT PCT PCT/US2014/061723 Expired
NCI E-190-2002-2-US-05 Identification Of A Novel BHD Gene US DIV 14/519,377 Abandoned
NIDDK E-284-2008-1-US-01 Combination Therapy Of TSHR Antagonist And IGFR Inhibitor US 62/066,193 Abandoned
NHLBI E-253-2014-0-US-01 Segmented Metallic Guidewires US 62/066,167 Abandoned
NCI E-002-2014-0-US-04 Human Monoclonal Antibodies Against The Middle East Respiratory Syndrome CoronaVirus (MERS-CoV) And Engineered Bispecific Fusions With Inhibitory Peptides US National Stage 15/030,165 10421802 Issued PDF
NCI E-002-2014-0-PCT-02 Human Monoclonal Antibodies Against The Middle East Respiratory Syndrome CoronaVirus (MERS-CoV) And Engineered Bispecific Fusions With Inhibitory Peptides PCT PCT PCT/US2014/060863 Expired
NCI E-002-2014-0-SA-03 Human Monoclonal Antibodies Against The Middle East Respiratory Syndrome CoronaVirus (MERS-CoV) And Engineered Bispecific Fusions With Inhibitory Peptides SA National Stage 516370963 Abandoned
NCI E-163-2009-0-US-04 B Cell Surface Reactive Antibodies US CON 14/514,851 Abandoned
NIAID E-043-2010-0-US-05 Infectious Hepatitis C Viruses of Genotype 3A and 4A and Uses Thereof US CON 14/514,023 9683269 Issued PDF
NIA E-139-2012-2-NL-10 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES NL EP 13727753.9 Issued
NIA E-139-2012-2-GB-09 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES GB EP 13727753.9 Issued
NIA E-139-2012-2-FR-08 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES FR EP 13727753.9 Issued
NIA E-139-2012-2-DE-07 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES DE EP 13727753.9 Issued
NCI E-242-2015-0-US-01 Peptide-Based Methods for Treating Pancreatic Cancer US 62/063,909 Abandoned
NCI E-344-2013-0-HK-01 TEM8 ANTIBODIES AND THEIR USE HK EP 42020013010.2 Issued
NCI E-344-2013-0-CA-04 TEM8 Antibodies and Their Use CA National Stage 2925393 Issued
NCI E-344-2013-0-MX-08 TEM8 Antibodies and Their Use MX National Stage MX/a/2016/003744 Issued
NCI E-344-2013-0-AU-03 TEM8 Antibodies and Their Use AU National Stage 2014331667 Issued
NCI E-344-2013-0-ES-13 TEM8 ANTIBODIES AND THEIR USE ES EP 14789480.2 Issued